Source - SMW
N+1 Singer today upgrades its investment rating on Oxford BioMedica PLC (LON:OXB) to hold (from sell) and set its price target at 330p.

Related Charts

Oxford BioMedica (OXB)

-0.02p (-0.57%)
delayed 18:15PM